DK294286A - Farmaceutisk praeparat omfattende en anabolisk androgen forbindelse og dets anvendelse - Google Patents

Farmaceutisk praeparat omfattende en anabolisk androgen forbindelse og dets anvendelse Download PDF

Info

Publication number
DK294286A
DK294286A DK294286A DK294286A DK294286A DK 294286 A DK294286 A DK 294286A DK 294286 A DK294286 A DK 294286A DK 294286 A DK294286 A DK 294286A DK 294286 A DK294286 A DK 294286A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
androgenic compound
anabolic androgenic
anabolic
compound
Prior art date
Application number
DK294286A
Other languages
English (en)
Other versions
DK294286D0 (da
Inventor
Paul A Knepper
Original Assignee
Paul A Knepper
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul A Knepper filed Critical Paul A Knepper
Publication of DK294286D0 publication Critical patent/DK294286D0/da
Publication of DK294286A publication Critical patent/DK294286A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK294286A 1984-10-22 1986-06-23 Farmaceutisk praeparat omfattende en anabolisk androgen forbindelse og dets anvendelse DK294286A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/663,507 US4617299A (en) 1983-12-19 1984-10-22 Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
PCT/US1985/002063 WO1986002554A1 (en) 1984-10-22 1985-10-21 A method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension

Publications (2)

Publication Number Publication Date
DK294286D0 DK294286D0 (da) 1986-06-23
DK294286A true DK294286A (da) 1986-08-21

Family

ID=24662106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK294286A DK294286A (da) 1984-10-22 1986-06-23 Farmaceutisk praeparat omfattende en anabolisk androgen forbindelse og dets anvendelse

Country Status (6)

Country Link
US (1) US4617299A (da)
EP (1) EP0199768A4 (da)
JP (1) JPS62501002A (da)
DK (1) DK294286A (da)
NO (1) NO862528D0 (da)
WO (1) WO1986002554A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812448A (en) * 1984-10-22 1989-03-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US5446177A (en) * 1984-12-28 1995-08-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US5223493A (en) * 1984-12-28 1993-06-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US5358943A (en) * 1987-12-29 1994-10-25 Clark Abbot F Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
US5407926A (en) * 1987-12-29 1995-04-18 Alcon Laboratories, Inc. Ophthalmic composition
US4945089A (en) * 1987-12-29 1990-07-31 Alcon Laboratories, Inc. Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5753237A (en) * 1989-09-25 1998-05-19 University Of Utah Research Foundation Method for augmenting immunological responses
DK0494224T3 (da) * 1989-09-25 2000-08-07 Univ Utah Res Found Anvendelse af steroidhormoner i sammensætninger til induktion af T-cellelymfokinproduktion
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
USRE34578E (en) * 1990-05-07 1994-04-05 Lubkin; Virginia Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
JP3328729B2 (ja) * 1991-06-18 2002-09-30 ラボラトアール、テラメックス、エス、ア 抗緑内障薬剤組成物
FR2679139B1 (fr) * 1991-07-17 1995-03-17 Theramex Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
EP1236470A3 (en) * 1991-11-22 2004-09-01 Alcon Laboratories, Inc. Angiostatic steroids
JPH07508716A (ja) * 1992-04-21 1995-09-28 ザ　スキーペンズ　アイ　リサーチ　インスティテュート，インコーポレイテッド シェーグレン症候群における眼のアンドロゲン療法
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
AU7622898A (en) * 1996-12-05 1998-06-29 Fenichel, Gerald The use of oxandrolone in the treatment of a neurological disorder
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6113542A (en) * 1998-12-15 2000-09-05 Hyman; George F. Diagnostic apparatus and method to provide effective intraocular pressure based on measured thickness of the cornea
US6410045B1 (en) 1999-02-22 2002-06-25 Clyde Lewis Schultz Drug delivery system for antiglaucomatous medication
US20020197300A1 (en) * 1999-02-22 2002-12-26 Schultz Clyde L. Drug delivery system for anti-glaucomatous medication
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
AU2003222668A1 (en) * 2002-04-25 2003-11-10 Rapidheal, Inc. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
WO2004093882A1 (ja) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute 眼に適用する疾患治療剤
EP1621199B8 (en) * 2003-04-18 2011-01-19 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
HUE033977T2 (en) 2004-08-23 2018-02-28 Sylentis Sau Treatment of eye disorders with siRNAs characterized by increased intraocular pressure
JP5544458B2 (ja) * 2005-07-12 2014-07-09 アンピオ ファーマシューティカルズ，インコーポレイテッド 疾病を治療するための医薬製品の製造においてトリロスタンｉｉｉを使用する方法及びトリロスタンｉｉｉを含む医薬製品
GB0521351D0 (en) * 2005-10-20 2005-11-30 Genomica Sau Modulation of TRPV expression levels
GB0521716D0 (en) * 2005-10-25 2005-11-30 Genomica Sau Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
US20100016264A1 (en) * 2007-12-05 2010-01-21 Connor Charles G Treatment for dry eye using testosterone and progestagen
JP5833549B2 (ja) 2009-06-22 2015-12-16 アンピオ ファーマシューティカルズ，インコーポレイテッド 血管透過性亢進を抑制するためのダナゾールを含む製薬組成物
EP2655656A1 (en) 2010-12-23 2013-10-30 Laurent Alexandre Method to obtain optical means adapted to a human individual suffering or susceptible to suffer from one or more genetic related eye disorder(s) or disease(s)
GB201215857D0 (en) 2012-09-05 2012-10-24 Sylentis Sau siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
AU2012389270B2 (en) 2012-09-05 2018-11-08 Sylentis S.A.U. siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
CN104968350A (zh) 2012-12-19 2015-10-07 安皮奥制药股份有限公司 疾病的治疗方法
US20150141328A1 (en) * 2013-11-18 2015-05-21 The Schepens Eye Research Institute Stimulation of human meibomian gland function
US10011837B2 (en) 2014-03-04 2018-07-03 Sylentis Sau SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions
DE102015107307B3 (de) * 2015-05-11 2016-09-08 Labor L + S Aktiengesellschaft Optisches Verfahren zur Gehaltsbestimmung von Hyaluronsäure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461829A (en) * 1981-09-14 1984-07-24 Miles Laboratories, Inc. Homogeneous specific binding assay element and lyophilization production method
DK493984A (da) * 1983-10-24 1985-04-25 Univ Texas Hybrid celle linier, monokloniske antistoffer frembragt med disse samt diagnosemetode under anvendelse af antistofferne

Also Published As

Publication number Publication date
WO1986002554A1 (en) 1986-05-09
EP0199768A4 (en) 1989-04-26
JPS62501002A (ja) 1987-04-23
DK294286D0 (da) 1986-06-23
US4617299A (en) 1986-10-14
EP0199768A1 (en) 1986-11-05
NO862528D0 (no) 1986-06-23

Similar Documents

Publication Publication Date Title
DK294286A (da) Farmaceutisk praeparat omfattende en anabolisk androgen forbindelse og dets anvendelse
KR880701554A (ko) 스테로이드제 함유 외용 첩부제
DK596385A (da) Peptidaldehyder og farmaceutiske praeparater indeholdende saadanne forbindelser
DE3665580D1 (en) Amide derivative and external medicament comprising same
DE3480262D1 (en) Percutaneous pharmaceutical preparations for external use
PH24049A (en) Substituted benzamide derivatives and pharmaceutical compositions containing the same
DK546786A (da) Veterinaerpraeparat
EP0070525A3 (en) Pharmaceutical preparations for external use
DK468386D0 (da) Direkte komprimerbart maltitolpulver og fremgangsmaade til dets fremstilling
DK475684D0 (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
GB2182323B (en) Settable compositions and methods of use thereof
DK57085D0 (da) Farmaceutisk praeparat indeholdende methylhydroxyprogesteronacetat og fremgangsmaade til dets fremstilling
NZ191709A (en) Naphtylmethyl-piperidines and pharmaceutical compostions intermediates
KR860005863A (ko) 자동닫힘 작용물과 자동닫힘 나사재료(Self-locking agent and self-locking screw waterial)
GB2130090B (en) Pharmaceutical preparations and compositions
NZ217871A (en) Oxazole derivatives and pharmaceutical compositions
DK381886D0 (da) Medicinsk praeparat og fremgangsmaade til dets fremstilling
DE3666431D1 (en) 2-(4-pyridylaminomethyl)-benzimidazole derivatives and pharmaceutical compositions
DK335587A (da) Vaeskefremmende veterinaerpraeparater
DK215883D0 (da) Farmaceutisk blandingspraeparat og dets fremstilling
GB8604134D0 (en) Veterinary preparations
PH23279A (en) Benzazole derivatives and pharmaceutical preparations containing such compounds and the use thereof
DK72186A (da) Oploesningsmiddel og dets anvendelse
DK151785D0 (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
ZA833817B (en) Aminobenzamide derivatives and preparation thereof

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment